Status:
COMPLETED
Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Fertility Preservation
Breast Cancer
Eligibility:
FEMALE
18-45 years
Brief Summary
This study will help the researchers learn more about factors that affect the decisions about fertility preservation and family building made by young women with breast cancer.
Eligibility Criteria
Inclusion
- Breast cancer, Stage 0-III
- Female
- 18-45 years of age at time of diagnosis
- Patients that completed their primary breast cancer treatment (surgery, chemotherapy, radiation therapy). Patients can still be on endocrine therapy, trastuzumab and/or pertuzumab therapy.
- Received education and counseling by MSK Fertility Nurse Specialist before beginning cancer treatment from 2009 through 2018
Exclusion
- Unable to read English
Key Trial Info
Start Date :
January 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 11 2025
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT03817814
Start Date
January 18 2019
End Date
August 11 2025
Last Update
August 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065